Braf-mutant Melanoma
📧 Sign up to get email alerts when something new happens for Braf-mutant Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-01-20Clinical Trial Update: Dabrafenib, Trametinib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma [Phase 1, Phase 2]
Phase 1/2 trial investigating dabrafenib, trametinib, and hydroxychloroquine in advanced BRAF-mutant melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-09-07Clinical Trial Update: LCCC 1128: Open Label Phase II Trial of the BRAF Inhibitor (Dabrafenib) and the MEK Inhibitor (Trametinib) in Unresectable Stage III and Stage IV BRAF Mutant Melanoma; Correlation of Resistance With the Kinome and Functional Mutations [Phase 2]
Phase II open-label trial evaluating dabrafenib plus trametinib in unresectable stage III/IV BRAF-mutant melanoma; study completed with post…